State-owned Shanghai Pharmaceuticals Holdings Co, one of China’s biggest pharmaceutical firms, announced the completion of its acquisition of the China drug distribution business of US pharmaceutical company Cardinal Health Inc for $576 million.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
